Advanced Biomedical Technologies Stock Net Income
| ABMT Stock | USD 0.0002 0.00 0.00% |
As of the 15th of February 2026, Advanced Biomedical shows the Mean Deviation of 3.01, standard deviation of 13.85, and Risk Adjusted Performance of 0.0536. Advanced Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Advanced Biomedical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Advanced Biomedical's valuation are summarized below:Advanced Biomedical Technologies does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Advanced |
Advanced Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Advanced Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Advanced Biomedical.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Advanced Biomedical on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Advanced Biomedical Technologies or generate 0.0% return on investment in Advanced Biomedical over 90 days. Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomat... More
Advanced Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Advanced Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Advanced Biomedical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0497 | |||
| Maximum Drawdown | 150.0 |
Advanced Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Advanced Biomedical's standard deviation. In reality, there are many statistical measures that can use Advanced Biomedical historical prices to predict the future Advanced Biomedical's volatility.| Risk Adjusted Performance | 0.0536 | |||
| Jensen Alpha | 0.8587 | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.40) |
Advanced Biomedical February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0536 | |||
| Market Risk Adjusted Performance | (0.39) | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | 1827.74 | |||
| Standard Deviation | 13.85 | |||
| Variance | 191.72 | |||
| Information Ratio | 0.0497 | |||
| Jensen Alpha | 0.8587 | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.40) | |||
| Maximum Drawdown | 150.0 | |||
| Skewness | 5.06 | |||
| Kurtosis | 44.43 |
Advanced Biomedical Backtested Returns
Advanced Biomedical appears to be out of control, given 3 months investment horizon. Advanced Biomedical secures Sharpe Ratio (or Efficiency) of 0.0556, which signifies that the company had a 0.0556 % return per unit of risk over the last 3 months. By analyzing Advanced Biomedical's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please makes use of Advanced Biomedical's Mean Deviation of 3.01, standard deviation of 13.85, and Risk Adjusted Performance of 0.0536 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Advanced Biomedical holds a performance score of 4. The firm shows a Beta (market volatility) of -1.85, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Advanced Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, Advanced Biomedical is expected to outperform it. Please check Advanced Biomedical's treynor ratio and day median price , to make a quick decision on whether Advanced Biomedical's price patterns will revert.
Auto-correlation | -0.23 |
Weak reverse predictability
Advanced Biomedical Technologies has weak reverse predictability. Overlapping area represents the amount of predictability between Advanced Biomedical time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Advanced Biomedical price movement. The serial correlation of -0.23 indicates that over 23.0% of current Advanced Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Advanced Biomedical Technologies reported net income of (672,000). This is 100.2% lower than that of the Health Care Equipment & Supplies sector and 100.28% lower than that of the Health Care industry. The net income for all United States stocks is 100.12% higher than that of the company.
Advanced Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Biomedical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Advanced Biomedical could also be used in its relative valuation, which is a method of valuing Advanced Biomedical by comparing valuation metrics of similar companies.Advanced Biomedical is currently under evaluation in net income category among its peers.
Advanced Fundamentals
| Return On Asset | -0.78 | |||
| Operating Margin | (3.86) % | |||
| Current Valuation | 3.52 M | |||
| Shares Outstanding | 70.22 M | |||
| Shares Owned By Insiders | 3.32 % | |||
| Price To Earning | (12.00) X | |||
| Price To Sales | 31.97 X | |||
| Revenue | 123.59 K | |||
| Gross Profit | 71.77 K | |||
| EBITDA | (282.69 K) | |||
| Net Income | (672 K) | |||
| Cash And Equivalents | 6.98 K | |||
| Total Debt | 6.36 M | |||
| Debt To Equity | (1.04) % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | 646.66 K | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 17 | |||
| Beta | 0.63 | |||
| Market Capitalization | 4.14 M | |||
| Total Asset | 469.23 K | |||
| Retained Earnings | (2.88 M) | |||
| Working Capital | (4.38 M) | |||
| Current Asset | 34 K | |||
| Current Liabilities | 4.42 M | |||
| Z Score | -19.2 | |||
| Net Asset | 469.23 K |
About Advanced Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Biomedical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Biomedical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.